Flemingsberg is a dynamic and multidisciplinary hub where collaboration between hospitals, academia, and industry continues to thrive, leading to groundbreaking advancements in Swedish cell and gene therapy, also known as Advanced Therapy Medicinal Products (ATMP). We have established ATMP Flemingsberg to provide a broader perspective on the Flemingsberg area based on the work being done within ATMP. Here, you will find the Karolinska ATMP Center, along with numerous companies and a vibrant campus. Our goal is to showcase everything the area has to offer and what makes Flemingsberg unique.

ATMPs are medicinal products based on cells, tissues, or genes, with the potential to cure diseases that were previously incurable. They are categorized into somatic cell therapies, gene therapies, tissue-engineered products, and combination products containing advanced therapy medicinal products. This enables entirely new ways of treating diseases and is revolutionizing healthcare.

Flemingsberg has long been at the forefront of ATMP development in Sweden. The geographical proximity between academic institutions and hospitals has created unique conditions for ATMP companies to establish themselves in the area. The hospital’s robust infrastructure has attracted companies that can conduct their research with the support of the expertise available in Flemingsberg. The ATMP Flemingsberg platform has been developed by the foundation to serve as a showcase for ATMP advancements in Flemingsberg, aiming to position the area as the premier choice for both national and international ATMP companies to establish themselves.

Visit ATMP Flemingsberg här >